Modifiable Etiological Factors and the Burden of Stroke from the Rotterdam Study: A Population-Based Cohort Study

PLoS Medicine

Volumn 11, Issue 4, 2014, Pages

  Bos, Michiel J ^a   Koudstaal, Peter J ^a   Hofman, Albert ^a   Ikram, M Arfan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOOD INTAKE; HEART ATRIUM FIBRILLATION; HUMAN; ICD-10; MALE; OBESITY; PREHYPERTENSION; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; COMPLICATION; COST OF ILLNESS; DIET; HYPERTENSION; MIDDLE AGED; NETHERLANDS; STROKE;

AGED; COHORT STUDIES; COST OF ILLNESS; DIET; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING; STROKE;

EID: 84900411569     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001634     Document Type: Article

References (29)

1. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202: 1028-1034.
2. Hankey GJ, (2006) Potential new risk factors for ischemic stroke: what is their potential? Stroke 37: 2181-2188.
3. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, et al. (2011) Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 517-584.
4. Rothman KJ, Greenland S, editors (1998) Modern epidemiology, 2nd edition. Philadelphia: Lippincott Williams & Wilkins.
5. Rothman KJ GS (1998) Causation and causal inference. In: Rothman KJ, Greenland S, editors. Modern epidemiology, 2nd edition. Philadelphia: Lipincott Williams & Wilkins. pp. 7-28.
6. Mallmann AB, Fuchs SC, Gus M, Fuchs FD, Moreira LB, (2012) Population-attributable risks for ischemic stroke in a community in South Brazil: a case-control study. PLoS ONE 7: e35680.
7. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, et al. (2010) Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 376: 112-123.
8. Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, et al. (2013) The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 28: 889-926.
9. Hatano S, (1976) Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 54: 541-553.
10. Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, et al. (2007) Incidence and prognosis of transient neurological attacks. JAMA 298: 2877-2885.
11. Clark TG, Altman DG, De Stavola BL, (2002) Quantification of the completeness of follow-up. Lancet 359: 1309-1310.
12. Rose GA, (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 27: 645-658.
13. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, et al. (2006) High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 114: 1591-1598.
14. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE, (1997) Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 96: 1432-1437.
15. van den Brandt PA, Goldbohm RA, van 't Veer P, Volovics A, Hermus RJ, et al. (1990) A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 43: 285-295.
16. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM, (2006) Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 37: 1503-1507.
17. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, et al. (2002) Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287: 3223-3229.
18. Gail D (2002) Interactive Risk Attributable Program, version 2.2 [computer program]. Available: http://dceg.cancer.gov/tools/risk-assessment/irap. Accessed 28 March 2014.
19. Dehghan A, van Hoek M, Sijbrands EJ, Stijnen T, Hofman A, et al. (2007) Risk of type 2 diabetes attributable to C-reactive protein and other risk factors. Diabetes Care 30: 2695-2699.
20. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, et al. (2003) Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95: 1404-1413.
21. Walter SD, (1998) Attributable risk in practice. Am J Epidemiol 148: 411-413.
22. Greenland S, (2001) Attributable fractions: bias from broad definition of exposure. Epidemiology 12: 518-520.
23. Bushnell CD, (2008) Stroke and the female brain. Nat Clin Pract Neurol 4: 22-33.
24. Wang X, Dong Y, Qi X, Huang C, Hou L, (2013) Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke 44: 1833-1839.
25. Whisnant JP, (1997) Modeling of risk factors for ischemic stroke. The Willis Lecture. Stroke 28: 1840-1844.
26. Ezzati M, Hoorn SV, Rodgers A, Lopez AD, Mathers CD, et al. (2003) Estimates of global and regional potential health gains from reducing multiple major risk factors. Lancet 362: 271-280.
27. C Reactive Protein Coronary Heart Disease Genetics Collaboration (2011) Wensley F, Gao P, Burgess S, Kaptoge S, et al. (2011) Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data. BMJ 342: d548.
28. Castilla Guerra L, del Carmen Fernandez Moreno M, Lopez Chozas JM, Jimenez Hernandez MD, (2008) Statins in stroke prevention: what an internist should know. Eur J Intern Med 19: 8-14.
29. Bos D, Portegies ML, van der Lugt A, Bos MJ, Koudstaal PJ, et al. (2014) Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam study. JAMA Neurol E-pub ahead of print. doi:10.1001/jamaneurol.2013.6223.